Enos Bernasconi

27.2k total citations · 1 hit paper
303 papers, 10.5k citations indexed

About

Enos Bernasconi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Enos Bernasconi has authored 303 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Infectious Diseases, 124 papers in Virology and 115 papers in Epidemiology. Recurrent topics in Enos Bernasconi's work include HIV/AIDS Research and Interventions (134 papers), HIV/AIDS drug development and treatment (125 papers) and HIV Research and Treatment (124 papers). Enos Bernasconi is often cited by papers focused on HIV/AIDS Research and Interventions (134 papers), HIV/AIDS drug development and treatment (125 papers) and HIV Research and Treatment (124 papers). Enos Bernasconi collaborates with scholars based in Switzerland, United States and United Kingdom. Enos Bernasconi's co-authors include Hansjakob Furrer, Bernard Hirschel, Matthias Cavassini, Manuel Battegay, Pietro Vernazza, Rainer Weber, Bruno Ledergerber, Martin Rickenbach, Amalio Telenti and Huldrych F. Günthard and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Enos Bernasconi

291 papers receiving 10.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

2011 466 citations Bruno Ledergerber, Hansjakob Furrer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enos Bernasconi Switzerland	56	7.2k	4.1k	4.0k	3.0k	1.3k	303	10.5k
Alexandra Calmy Switzerland	53	6.5k 0.9×	3.8k 0.9×	3.2k 0.8×	3.3k 1.1×	801 0.6×	305	10.1k
Sharon Walmsley Canada	47	6.6k 0.9×	4.2k 1.0×	4.0k 1.0×	1.9k 0.7×	825 0.7×	331	10.8k
Matthias Cavassini Switzerland	58	7.8k 1.1×	5.0k 1.2×	3.7k 0.9×	3.0k 1.0×	1.1k 0.9×	367	11.8k
Amanda Mocroft United Kingdom	55	9.4k 1.3×	5.0k 1.2×	5.2k 1.3×	4.7k 1.6×	1.8k 1.4×	250	13.2k
Hansjakob Furrer Switzerland	64	9.2k 1.3×	5.0k 1.2×	5.6k 1.4×	3.1k 1.0×	1.7k 1.4×	276	14.3k
Anne C. Moorman United States	38	8.7k 1.2×	5.4k 1.3×	6.1k 1.5×	4.0k 1.3×	2.5k 2.0×	124	14.1k
Niels Obel Denmark	47	4.3k 0.6×	2.3k 0.6×	3.2k 0.8×	2.6k 0.9×	723 0.6×	317	8.4k
Jack Fuhrer United States	19	6.2k 0.9×	4.2k 1.0×	3.4k 0.8×	2.5k 0.8×	534 0.4×	33	9.3k
Judith A. Aberg United States	51	5.9k 0.8×	2.5k 0.6×	3.0k 0.7×	2.9k 1.0×	543 0.4×	200	9.2k
Anton Pozniak United Kingdom	53	8.2k 1.1×	5.2k 1.3×	3.5k 0.9×	1.9k 0.6×	747 0.6×	294	10.7k

Countries citing papers authored by Enos Bernasconi

Since Specialization

Citations

This map shows the geographic impact of Enos Bernasconi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enos Bernasconi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enos Bernasconi more than expected).

Fields of papers citing papers by Enos Bernasconi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enos Bernasconi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enos Bernasconi. The network helps show where Enos Bernasconi may publish in the future.

Co-authorship network of co-authors of Enos Bernasconi

This figure shows the co-authorship network connecting the top 25 collaborators of Enos Bernasconi. A scholar is included among the top collaborators of Enos Bernasconi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enos Bernasconi. Enos Bernasconi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taghavi, Katayoun, Chloé Pasin, Philip Tarr, et al.. (2025). Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study. HIV Medicine. 26(12). 1963–1972.

Esteban-Cantos, Andrés, Christian Thorball, Berta Rodés, et al.. (2023). Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet Healthy Longevity. 4(5). e211–e218. 21 indexed citations

Bernasconi, Enos, et al.. (2023). A case of spondylodiscitis by Ureaplasma urealyticum in an immunocompetent adult with spine stabilization. International Journal of Infectious Diseases. 131. 127–129. 1 indexed citations

Hentzien, Maxime, Jaromil Frossard, Roger D. Kouyos, et al.. (2023). External validation of the Dat'AIDS score: A risk score for predicting 5‐year overall mortality in people living with HIV aged 60 years or older. HIV Medicine. 25(1). 72–82.

Baumann, Lukas, Dominique L. Braun, Matthias Cavassini, et al.. (2023). Long‐term trends in hepatitis C prevalence, treatment uptake and liver‐related events in the Swiss HIV Cohort Study. Liver International. 44(1). 169–179. 1 indexed citations

Cottler-Casanova, Sara, Matthias Cavassini, Marcel Stoeckle, et al.. (2022). Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study. Journal of Immigrant and Minority Health. 25(1). 136–141. 3 indexed citations

Surial, Bernard, Catrina Mugglin, Alexandra Calmy, et al.. (2021). Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV. Annals of Internal Medicine. 174(6). 758–767. 79 indexed citations

Surial, Bernard, Nicolas Bertholet, Jean‐Bernard Daeppen, et al.. (2021). The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study. Journal of Clinical Medicine. 10(2). 295–295. 11 indexed citations

Nguyen, Huyen, Christian Thorball, Jacques Fellay, et al.. (2021). Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link. eLife. 10. 4 indexed citations

10.

Kusejko, Katharina, Huldrych F. Günthard, Gregory S. Olson, et al.. (2020). Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV. PLoS Biology. 18(12). e3000963–e3000963. 8 indexed citations

11.

Combes, Jean‐Damien, Gary M. Clifford, Huldrych F. Günthard, et al.. (2019). Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction. International Journal of Cancer. 147(3). 757–765. 7 indexed citations

12.

Hampel, Benjamin, Katharina Kusejko, Roger D. Kouyos, et al.. (2019). Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV Medicine. 21(4). 228–239. 51 indexed citations

13.

Aebi‐Popp, Karoline, Gilles Wandeler, Luisa Salazar‐Vizcaya, et al.. (2018). Rapid decline of anti‐hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV‐infected men who have sex with men. HIV Medicine. 19(6). 420–425. 13 indexed citations

14.

Elzi, Luigia, Stefan Erb, Hansjakob Furrer, et al.. (2017). Adverse events of raltegravir and dolutegravir. AIDS. 31(13). 1853–1858. 86 indexed citations

15.

Cecchinato, Valentina, Enos Bernasconi, Roberto F. Speck, et al.. (2016). Impairment of CCR6+ and CXCR3+ Th Cell Migration in HIV-1 Infection Is Rescued by Modulating Actin Polymerization. The Journal of Immunology. 198(1). 184–195. 19 indexed citations

16.

Bibert, Stéphanie, Agnieszka Wójtowicz, Patrick Taffé, et al.. (2014). The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. AIDS. 28(13). 1885–1889. 34 indexed citations

17.

Vernazza, Pietro, et al.. (2008). HIV-infizierte Menschen ohne andere STD sind unter wirksamer antiretroviraler Therapie sexuell nicht infektiös. Schweizerische Ärztezeitung. 89(5). 165–169. 27 indexed citations

18.

Vernazza, Pietro, et al.. (2008). Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des Médecins Suisses. 89(5). 165–169. 195 indexed citations

19.

Vernazza, Pietro, Enos Bernasconi, & Bernard Hirschel. (2000). [HIV superinfection: myth or reality?].. PubMed. 130(31-32). 1101–4. 5 indexed citations

20.

Bassetti, Stefano, Manuel Battegay, Martin Rickenbach, et al.. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued ?. IRIS. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact